Healthcare
Zentek Ltd.(ZTEK)
Live Price
Offline$0.432
-6.09% today
1Y Change
-66.51%
Window
Jun 23, 2025 → Jun 15, 2026
- Market Cap
- $70.00M
- Revenue Growth
- +2826.3%
- EPS Growth
- +16.7%
- Dividend Yield
- 0.0%
Coverage: 246 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Zentek Ltd. (ZTEK) is a Healthcare stock with a market cap of $70.00M and listed on NASDAQ. The stock last traded around $0.43 and down 66.5% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +2826.3%, EPS growth of +16.7%, a dividend yield of 0.0%. What stands out right now is revenue +2826.3%, EPS +16.7%, free cash flow -1.7% with operating margin -928.4% and ROIC -61.5%. Valuation already assumes a fairly strong business story at price/sales 77.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines ZTEK price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+2826.3% vs +7.6% peer median
Operating Margin
Below sector median
-928.4% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating story is still moving forward
Revenue is running at +2826.3% and EPS at +16.7%, with operating margin around -928.4%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ZTEK
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ZTEK Max Drawdown
-68.42%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ZTEK and SPY.
Company Overview
Zentek Ltd.
NASDAQ Capital Market
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
- Leadership
- Mohammed Jiwan
- IPO Date
- Apr 2, 2012
- Employees
- 24
- Street Address
- 1205 Amber Drive
- Mailing
- Guelph, ON, P7B 6M4
- Region
- Guelph, ON, CA
- Reporting Currency
- USD
- Investor Line
- 844 730 9822
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 77.6
- Price/Book
- 5.9
Growth
- Revenue
- +2826.3%
- EPS
- +16.7%
- Free Cash Flow
- -1.7%
Profitability
- Gross Margin
- -74.8%
- Operating Margin
- -928.4%
- Net Margin
- -857.1%
- ROE
- -61.3%
- ROIC
- -61.5%
Balance Sheet
- Debt/Equity
- 0.15
- Current Ratio
- 1.00
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.